Annual Drug Patent Expirations for DIFFERIN
Differin is a drug marketed by Galderma Labs Lp and is included in five NDAs. It is available from five suppliers. There are nine patents protecting this drug and one Paragraph IV challenge.
This drug has fifty patent family members in twenty-two countries.
The generic ingredient in DIFFERIN is adapalene. Five suppliers are listed for this compound. Additional details are available on the adapalene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com